In a clinical laboratory, an automated hematology analyzer brings sample handling, cell measurement and results processing into a coordinated workflow. The Sysmex XE-5000 is one example: its 510(k) summary describes an instrument designed to analyze anticoagulated blood and specified body fluids, with automated sampling, multiple detection methods and an information-processing unit for displaying and transmitting results. For laboratory and automation professionals, the system illustrates how analytical methods, sample transport and software functions are combined in a diagnostic instrument.
How the XE-5000 organizes the analysis workflow
The XE-5000 consists of three principal units. The main unit aspirates, dilutes and mixes samples before analysis. An autosampler supplies samples to the main unit, while the information-processing unit (IPU) processes data and provides the operator interface. The sampler is described as supporting continuous automated sampling for up to 100 tubes.
This arrangement links physical sample handling with measurement and result management. After analysis, results and graphics appear on the IPU screen. They can also be printed using an available printer or transmitted to a host computer. The system’s workflow therefore covers more than measurement alone: it includes sample presentation, data processing and routes for making results available to laboratory systems and personnel.
Detection methods and cell characterization
The analyzer uses three methods: RF/DC detection, sheath-flow DC detection and flow cytometry using a semiconductor laser. Together, these methods provide different forms of information about cells.
- RF/DC detection: Changes in direct-current resistance indicate cell size, while changes in radio-frequency resistance provide information about the density of the cell interior.
- Sheath-flow detection: Cells pass through a detector aperture surrounded by sheath fluid, supporting their passage through the measurement area.
- Flow cytometry: A semiconductor laser illuminates cells passing through a flow cell. Forward-scattered light is received by a photodiode; lateral-scattered and lateral fluorescent light are received by a photomultiplier tube. These optical signals are converted into electrical pulses for cell characterization.
For particle characterization and identification, the XE-5000 uses forward scatter, fluorescence and adaptive cluster analysis. In practical terms, the instrument combines electrical and optical signals rather than relying on a single measurement principle. The 510(k) summary states that the XE-5000 uses the same methods and reagents as the XE-2100 predicate device.
Automated hematology analyzer parameters and body fluid mode
For whole-blood testing, the XE-5000 classifies and enumerates the same parameters as the XE-2100, with additional capabilities described in the submission. Reported measures include red and white blood cell counts, hemoglobin, hematocrit, platelet count and red-cell indices. The listed parameters also include differential counts for neutrophils, lymphocytes, monocytes, eosinophils and basophils, as well as reticulocyte, immature granulocyte and other specialized measurements. Cord blood is specified for hematopoietic progenitor cell (HPC) analysis.
The body fluid mode is intended for cerebrospinal fluid (CSF), serous fluids and synovial fluids, with EDTA as needed. It reports:
- WBC-BF and RBC-BF counts for white and red blood cells in body fluid;
- mononuclear cell (MN) and polymorphonuclear cell (PMN) percentages and counts within the white blood cell population; and
- TC-BF, a total count that includes WBC-BF and particles appearing in a stronger fluorescence area of the DIFF scattergram.
The summary describes this mode as using a 4DIFF scattergram and red-cell distribution from a specialized analysis sequence to calculate and display these results. It also identifies lower-level cell detection and body-fluid differential parameters as differences from the predicate analyzer. Those details matter when evaluating an analyzer for a particular laboratory workflow: the intended specimen types and reported parameters need to match the lab’s testing requirements.
What the 510(k) comparison establishes
The FDA’s 2007 510(k) letter determined the XE-5000 to be substantially equivalent, for the stated indications for use, to legally marketed predicate devices. The submission identifies the XE-2100 Body Fluid application as the predicate and describes the XE-5000 as a modification within the XE-Series.
The comparison reports shared detection methods, reagents, specimen types and approximate throughput of 113–150 samples per hour, depending on the mode used. It also describes differences, including body-fluid parameters, capillary-mode parameters and additional software masters. For the body fluid mode, the submission says comparison testing demonstrated excellent correlation with the XE-2100 Body Fluid application and describes performance data for carryover, linearity, accuracy and reproducibility against manufacturer specifications.
Substantial equivalence is a regulatory determination for the device’s stated indications; it is not a general finding about every laboratory’s performance or workflow. The FDA letter also notes that the determination does not remove other applicable regulatory responsibilities. Laboratories and technical decision-makers should distinguish the scope of a 510(k) decision from their own implementation, validation and operational requirements.
Practical considerations for laboratory automation
The XE-5000’s architecture highlights several considerations when assessing automated diagnostic equipment:
- Sample flow: Review how specimens are loaded and supplied to the analytical unit, including the role and stated capacity of the autosampler.
- Measurement approach: Understand how electrical impedance and optical signals contribute to cell analysis and classification.
- Result handling: Consider how results are displayed, printed or transmitted to a host computer within the laboratory workflow.
- Test scope: Confirm that the available specimen modes and parameters correspond to intended clinical laboratory use.
The Sysmex XE-5000 combines automated sample processing, multiple cell-detection methods and dedicated body fluid analysis in a single hematology analyzer. Its 510(k) summary provides a clear view of the system’s intended use and how it compares with its predicate, while also defining the limits of that regulatory conclusion. For laboratory automation teams, the practical lesson is to assess the entire workflow—from specimen handling through measurement and result delivery—alongside the analyzer’s approved testing scope.